This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Hepatitis C Virus (HCV) Testing Market

Interested in exploring key trends and breakthroughs in Hepatitis C Virus (HCV) Testing? FMI presents its exhaustive findings on the subject

Hepatitis C Virus (HCV) Testing Market by Technique, End User, Test Type & Region - Forecast 2022 – 2032

Hepatitis C Virus Testing Market Outlook (2022-2032)

[297 Pages Report] The global hepatitis C virus (HCV) testing market is expected to accumulate US$ 733.6 Million in value by 2022-end. During the forecast period ranging from 2022 to 2032, a CAGR worth 5.6% has been projected for the market, with an expected closing value worth US$ 1341.7 Million. During the 2016-2021 historical period, the industry grew at a value CAGR worth 6%.

The growing burden of infectious diseases on the global healthcare system is a major consideration, with developing countries bearing a disproportionate share of the burden. Over time, the burden of hepatitis C virus infection has accelerated. According to the Institute of Liver and Biliary Sciences India, approximately 3% of the world's population is infected with the hepatitis C virus.

Data Points

Key Statistics

Global Market CAGR (2022-2032)

5.6%

Anticipated Market Value (2022)

US$ 733.6 Million

Global Market (2032)

US$ 1,341.7 Million

Global Market Attraction

The rising prevalence of hepatitis C virus infection is the primary driver of the global hepatitis C virus testing market. Inadequate blood donation strategies are the leading cause of hepatitis C virus infection.

The growing burden of infectious diseases on the global healthcare system is a major consideration, with developing countries bearing a disproportionate share of the burden. Over time, the burden of hepatitis C virus infection has accelerated. According to the Institute of Liver and Biliary Sciences India, approximately 3% of the world's population is infected with the hepatitis C virus.

In 80 percent of infected patients, HCV did cause chronic infection. Initial hepatitis C virus testing employs serological assays to detect antibodies against HCV in blood samples. According to the most last several Centers for Disease Control and Prevention (CDC) guidelines for hepatitis C screening, a cut-off ratio for anti-HPV antibodies is added, which aids in the selection of additional assays for confirmation of screening results.

The nucleic acid amplification test (NAT) is used to confirm and determine viral load. Regarding all constructive antibody tests, an RNA test is performed. HCV genotyping tests are used in clinical HPV management to determine viral load and optimal treatment duration. In the long run Injection drug use, as well as the use of non-sterile needles for tattooing and body piercing, are common causes of hepatitis C virus infection spread.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Are The Factors Propelling The Global Hepatitis C Virus Testing Market?

The rising prevalence of hepatitis C virus infection is the primary driver of the global hepatitis C virus testing market. Inadequate blood donation strategies are the leading cause of hepatitis C virus infection. Hepatitis C screening is required before organ donation, and growing organ donation projects around the world are expected to drive future growth.

The introduction of point-of-care testing products for HCV testing raises the potential for HCV testing kits. The FDA approved the OraQuick HCV Rapid Antibody Test in 2010, and it is now widely used as an alternative to enzyme immunoassay testing for HCV. The use of new electrochemical immuno sensor and nano sensor technologies in HPV testing is expected to change current practices.

What Are The Factors Hampering The Global Hepatitis C Virus Testing Market?

However, insufficient insurance coverage for hepatitis C testing and limited access to regular health care are restricting the global hepatitis C virus testing industry.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why Is North America Emerging As An Opportunistic Hepatitis C Virus Testing Market?

An estimated 12.5-40% of detained people in North America have HCV-antibody positivity, supporting the recommendation to screen this population for HCV infection and increasing market demand.

Infection with the Hepatitis C virus (HCV) is a leading cause of morbidity and mortality in the United States. HCV is primarily transmitted via parenteral exposure to infectious blood or body fluids containing blood, most commonly through injection drug use. With 8-12 weeks of all-oral medication regimens, direct-acting antiviral treatment can result in a virologic cure in most people; this factor is increasing market demand in North America.

HCV infection rates nearly doubled among women with live births in North America between 2009 and 2014, as new HCV infections increased among reproductive-aged adults. As a result, this factor will drive market growth in this region. As per Future Market Insights, North America is likely to account for 33.2% of the global Hepatitis C virus testing market in 2022.

Why Is The Demand For Hepatitis C Virus Testing Burgeoning In Europe?

In 2022, Europe is forecast to account for a 30.6% share in the hepatitis C virus testing market, and is projected to maintain this growth throughout the forecast period, states Future Market Insights.

According to a research paper published in the medical journal BMJ Open in August 2020, HCV diagnosis rates in Germany are projected to exceed 70% by 2030 under current approach. Such encouraging trends in HCV testing in the country are expected to significantly aid market growth during the forecast period.

In Europe, Hepatitis C is one of the most common infectious diseases. Several initiatives in the region have been inaugurated to better understand disease trends, such as prevalence and the most widely known genotypes. It is a liver disease caused by the hepatitis C virus (HCV), and it can contribute to the development of liver cancer if left untreated.

While Germany has historically had a lower prevalence of hepatitis C than developing countries, the country's demographics have changed in recent years. The increasing influx of migrants and rising drug abuse through injections among the general population are projected to augment the country's hepatitis C prevalence.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

How Start-Ups Are Adding Value To The Global Hepatitis C Virus Testing Market?

The swelling dispersion of start-ups in the Hepatitis C Virus Testing market has improved the product quality and elevated global sales. Besides, to gain a competitive edge, new start-ups are working on novel developments and launching new products. Some notable players offering hepatitis C virus testing kits are as follows:

  • NATSpert, established in 2017 in Pune, India, is a developer of blood detection kits for viral diseases. Its product- NATSpert ID TripleH is a qualitative, real-time PCR test for simultaneous detection of HIV, HBV and HCV respectively. The kit comes in a single tube format, and allows for screening of HIV type 1 group M-RNA, HIV-1 group-O RNA, HIV-2 RNA, Hepatitis C Virus RNA and Hepatitis B Virus DNA in human blood plasma
  • Founded in 2005, HepC is a developer of antiviral biologic products. The company deploys IBDV, a non-pathogenic double-stranded RNA virus. This virus acts as a master activator of antiviral gene responses as its primary vector system. Its product development includes HC001 for treating advanced chronic viral hepatitis caused by HBV and HCV infections

Who Are The Key Players In The Global Hepatitis C Virus Testing Market?

Some of the manufacturers identified in the global hepatitis C virus testing market include OraSure Technologies, Inc., Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Ortho Clinical Diagnostic Inc. (Johnson & Johnson), Bayer AG, QIAGEN N.V., Thermo Fisher Scientific Inc., BioGenex, AccuQuick, Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits, etc. among others.

The key development in the Hepatitis C Virus Testing market is as follows:

  • Access Bio Inc. and Atomo Diagnostics announced the development of a rapid diagnostic test (RDT) for screening for hepatitis C virus in April 2019. (HCV). The tests were commercially available by the end of this year 2019.
  • Gilead Sciences Inc. announced the HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia in March 2019.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.6% from 2022 to 2032

Market Value in 2022

US$ 733.6 Million

Market Value in 2032

US$ 1,341.7 Million

Base Year for Estimation

2021

Historical Period

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Technique
  • End User
  • Test Type
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • OraSure Technologies, Inc.
  • Abbott Laboratories Inc.
  • Siemens Healthcare GmbH
  • Bio Rad Laboratories Inc.
  • Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
  • Bayer AG
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • BioGenex
  • AccuQuick,
  • Roche Diagnostics (F. Hoffman-La Roche Ltd.)
  • STD Rapid Test Kits

Customization

Available Upon Request

Key Segments Covered In The Hepatitis C Virus (HCV) Industry Survey

Hepatitis C Virus (HCV) Testing Market by Technique:

  • Immunoassays-based Hepatitis C Virus Testing
  • Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
  • Other Hepatitis C Virus Testing Techniques

Hepatitis C Virus (HCV) Testing Market by Test Type:

  • HCV Antibody Testing
  • HCV Viral Load Testing
  • HCV Genotyping Testing

Hepatitis C Virus (HCV) Testing Market by End User:

  • Hepatitis C Virus Testing in Hospitals
  • Hepatitis C Virus Testing in Diagnostic Centers
  • Hepatitis C Virus Testing in Blood Donation Centers

Hepatitis C Virus (HCV) Testing Market by Region:

  • North America Hepatitis C Virus Testing Market
  • Latin America Hepatitis C Virus Testing Market
  • Europe Hepatitis C Virus Testing Market
  • Asia Pacific Hepatitis C Virus Testing Market
  • Middle East & Africa Hepatitis C Virus Testing Market

Frequently Asked Questions

The global hepatitis C virus testing market is likely to be valued at US$ 733.6 Million in 2022.

The hepatitis C virus testing market is estimated to grow at a CAGR of 5.6% from 2022 to 2032.

The hepatitis C virus testing market is predicted to procure US$ 1341.7 Million by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Technique

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Technique, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technique, 2022-2032

        5.3.1. Immunoassays

        5.3.2. Polymerase Chain Reaction (PCR)

        5.3.3. Others

    5.4. Y-o-Y Growth Trend Analysis By Technique, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Technique, 2022-2032

6. Global Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Test type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Test type, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test type, 2022-2032

        6.3.1. HCV Antibody Tests

        6.3.2. HCV Viral Load Tests

        6.3.3. HCV Genotyping Tests

    6.4. Y-o-Y Growth Trend Analysis By Test type, 2016-2021

    6.5. Absolute $ Opportunity Analysis By Test type, 2022-2032

7. Global Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2016-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Diagnostic Centers

        7.3.3. Blood Donation Centers

    7.4. Y-o-Y Growth Trend Analysis By End User, 2016-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Technique

        9.2.3. By Test type

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Technique

        9.3.3. By Test type

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Technique

        10.2.3. By Test type

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Technique

        10.3.3. By Test type

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Technique

        11.2.3. By Test type

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Technique

        11.3.3. By Test type

        11.3.4. By End User

    11.4. Key Takeaways

12. Asia Pacific Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. Malaysia

            12.2.1.5. Singapore

            12.2.1.6. Australia

            12.2.1.7. Rest of Asia Pacific

        12.2.2. By Technique

        12.2.3. By Test type

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Technique

        12.3.3. By Test type

        12.3.4. By End User

    12.4. Key Takeaways

13. MEA Hepatitis C Virus (HCV) Testing Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Technique

        13.2.3. By Test type

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Technique

        13.3.3. By Test type

        13.3.4. By End User

    13.4. Key Takeaways

14. Key Countries Hepatitis C Virus (HCV) Testing Market Analysis

    14.1. U.K.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Technique

            14.1.2.2. By Test type

            14.1.2.3. By End User

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Technique

            14.2.2.2. By Test type

            14.2.2.3. By End User

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Technique

            14.3.2.2. By Test type

            14.3.2.3. By End User

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Technique

            14.4.2.2. By Test type

            14.4.2.3. By End User

    14.5. Rest of Latin America

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Technique

            14.5.2.2. By Test type

            14.5.2.3. By End User

    14.6. Germany

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Technique

            14.6.2.2. By Test type

            14.6.2.3. By End User

    14.7. U.K.

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Technique

            14.7.2.2. By Test type

            14.7.2.3. By End User

    14.8. France

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Technique

            14.8.2.2. By Test type

            14.8.2.3. By End User

    14.9. Spain

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Technique

            14.9.2.2. By Test type

            14.9.2.3. By End User

    14.10. Italy

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Technique

            14.10.2.2. By Test type

            14.10.2.3. By End User

    14.11. Rest of Europe

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Technique

            14.11.2.2. By Test type

            14.11.2.3. By End User

    14.12. China

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Technique

            14.12.2.2. By Test type

            14.12.2.3. By End User

    14.13. Japan

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Technique

            14.13.2.2. By Test type

            14.13.2.3. By End User

    14.14. South Korea

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Technique

            14.14.2.2. By Test type

            14.14.2.3. By End User

    14.15. Malaysia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Technique

            14.15.2.2. By Test type

            14.15.2.3. By End User

    14.16. Singapore

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Technique

            14.16.2.2. By Test type

            14.16.2.3. By End User

    14.17. Australia

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Technique

            14.17.2.2. By Test type

            14.17.2.3. By End User

    14.18. Rest of Asia Pacific

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Technique

            14.18.2.2. By Test type

            14.18.2.3. By End User

    14.19. GCC Countries

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Technique

            14.19.2.2. By Test type

            14.19.2.3. By End User

    14.20. South Africa

        14.20.1. Pricing Analysis

        14.20.2. Market Share Analysis, 2021

            14.20.2.1. By Technique

            14.20.2.2. By Test type

            14.20.2.3. By End User

    14.21. Israel

        14.21.1. Pricing Analysis

        14.21.2. Market Share Analysis, 2021

            14.21.2.1. By Technique

            14.21.2.2. By Test type

            14.21.2.3. By End User

    14.22. Rest of MEA

        14.22.1. Pricing Analysis

        14.22.2. Market Share Analysis, 2021

            14.22.2.1. By Technique

            14.22.2.2. By Test type

            14.22.2.3. By End User

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Technique

        15.3.3. By Test type

        15.3.4. By End User

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. OraSure Technologies, Inc.

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Abbott Laboratories Inc.

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Siemens Healthcare GmbH

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Bio Rad Laboratories Inc.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Bayer AG

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. QIAGEN N.V.

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Thermo Fisher Scientific Inc.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. BioGenex

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. AccuQuick

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

        16.1.11. Roche Diagnostics (H. Hoffman-La Roche Ltd.)

            16.1.11.1. Overview

            16.1.11.2. Product Portfolio

            16.1.11.3. Profitability by Market Segments

            16.1.11.4. Sales Footprint

            16.1.11.5. Strategy Overview

                16.1.11.5.1. Marketing Strategy

        16.1.12. STD Rapid Test Kits

            16.1.12.1. Overview

            16.1.12.2. Product Portfolio

            16.1.12.3. Profitability by Market Segments

            16.1.12.4. Sales Footprint

            16.1.12.5. Strategy Overview

                16.1.12.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 02: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Technique, 2016-2032

Table 03: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Test type, 2016-2032

Table 04: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 05: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 06: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Technique, 2016-2032

Table 07: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Test type, 2016-2032

Table 08: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 09: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 10: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Technique, 2016-2032

Table 11: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Test type, 2016-2032

Table 12: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 13: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Technique, 2016-2032

Table 15: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Test type, 2016-2032

Table 16: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 17: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 18: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Technique, 2016-2032

Table 19: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Test type, 2016-2032

Table 20: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 21: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 22: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Technique, 2016-2032

Table 23: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by Test type, 2016-2032

Table 24: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Forecast by End User, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Technique, 2022-2032

Figure 02: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Test type, 2022-2032

Figure 03: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 04: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Region, 2022-2032

Figure 05: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 06: Global Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 07: Global Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 08: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Technique, 2016-2032

Figure 09: Global Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 10: Global Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 11: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Test type, 2016-2032

Figure 12: Global Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Test type, 2022-2032

Figure 13: Global Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Test type, 2022-2032

Figure 14: Global Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 15: Global Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 16: Global Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 17: Global Hepatitis C Virus (HCV) Testing Market Attractiveness by Technique, 2022-2032

Figure 18: Global Hepatitis C Virus (HCV) Testing Market Attractiveness by Test type, 2022-2032

Figure 19: Global Hepatitis C Virus (HCV) Testing Market Attractiveness by End User, 2022-2032

Figure 20: Global Hepatitis C Virus (HCV) Testing Market Attractiveness by Region, 2022-2032

Figure 21: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Technique, 2022-2032

Figure 22: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Test type, 2022-2032

Figure 23: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 24: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 26: North America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Technique, 2016-2032

Figure 29: North America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 30: North America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 31: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Test type, 2016-2032

Figure 32: North America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Test type, 2022-2032

Figure 33: North America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Test type, 2022-2032

Figure 34: North America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 35: North America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 36: North America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 37: North America Hepatitis C Virus (HCV) Testing Market Attractiveness by Technique, 2022-2032

Figure 38: North America Hepatitis C Virus (HCV) Testing Market Attractiveness by Test type, 2022-2032

Figure 39: North America Hepatitis C Virus (HCV) Testing Market Attractiveness by End User, 2022-2032

Figure 40: North America Hepatitis C Virus (HCV) Testing Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Technique, 2022-2032

Figure 42: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Test type, 2022-2032

Figure 43: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 44: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 46: Latin America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Technique, 2016-2032

Figure 49: Latin America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 50: Latin America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 51: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Test type, 2016-2032

Figure 52: Latin America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Test type, 2022-2032

Figure 53: Latin America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Test type, 2022-2032

Figure 54: Latin America Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 55: Latin America Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 56: Latin America Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 57: Latin America Hepatitis C Virus (HCV) Testing Market Attractiveness by Technique, 2022-2032

Figure 58: Latin America Hepatitis C Virus (HCV) Testing Market Attractiveness by Test type, 2022-2032

Figure 59: Latin America Hepatitis C Virus (HCV) Testing Market Attractiveness by End User, 2022-2032

Figure 60: Latin America Hepatitis C Virus (HCV) Testing Market Attractiveness by Country, 2022-2032

Figure 61: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Technique, 2022-2032

Figure 62: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Test type, 2022-2032

Figure 63: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 64: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 66: Europe Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Technique, 2016-2032

Figure 69: Europe Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 70: Europe Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 71: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Test type, 2016-2032

Figure 72: Europe Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Test type, 2022-2032

Figure 73: Europe Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Test type, 2022-2032

Figure 74: Europe Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 75: Europe Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 76: Europe Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 77: Europe Hepatitis C Virus (HCV) Testing Market Attractiveness by Technique, 2022-2032

Figure 78: Europe Hepatitis C Virus (HCV) Testing Market Attractiveness by Test type, 2022-2032

Figure 79: Europe Hepatitis C Virus (HCV) Testing Market Attractiveness by End User, 2022-2032

Figure 80: Europe Hepatitis C Virus (HCV) Testing Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Technique, 2022-2032

Figure 82: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Test type, 2022-2032

Figure 83: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 84: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 86: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Technique, 2016-2032

Figure 89: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 90: Asia Pacific Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 91: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Test type, 2016-2032

Figure 92: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Test type, 2022-2032

Figure 93: Asia Pacific Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Test type, 2022-2032

Figure 94: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 95: Asia Pacific Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 96: Asia Pacific Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 97: Asia Pacific Hepatitis C Virus (HCV) Testing Market Attractiveness by Technique, 2022-2032

Figure 98: Asia Pacific Hepatitis C Virus (HCV) Testing Market Attractiveness by Test type, 2022-2032

Figure 99: Asia Pacific Hepatitis C Virus (HCV) Testing Market Attractiveness by End User, 2022-2032

Figure 100: Asia Pacific Hepatitis C Virus (HCV) Testing Market Attractiveness by Country, 2022-2032

Figure 101: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Technique, 2022-2032

Figure 102: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Test type, 2022-2032

Figure 103: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 104: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 106: MEA Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Technique, 2016-2032

Figure 109: MEA Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 110: MEA Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 111: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by Test type, 2016-2032

Figure 112: MEA Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by Test type, 2022-2032

Figure 113: MEA Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by Test type, 2022-2032

Figure 114: MEA Hepatitis C Virus (HCV) Testing Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 115: MEA Hepatitis C Virus (HCV) Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: MEA Hepatitis C Virus (HCV) Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: MEA Hepatitis C Virus (HCV) Testing Market Attractiveness by Technique, 2022-2032

Figure 118: MEA Hepatitis C Virus (HCV) Testing Market Attractiveness by Test type, 2022-2032

Figure 119: MEA Hepatitis C Virus (HCV) Testing Market Attractiveness by End User, 2022-2032

Figure 120: MEA Hepatitis C Virus (HCV) Testing Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Rapid Hepatitis Testing Market

Published : July 2021

Healthcare

Ischemic Hepatitis Treatment Market

Published : January 2019

Healthcare

Hepatitis B Diagnostic Tests Market

Published : January 2022

Healthcare

Hepatitis - B Therapeutics Market

Published : February 2016

Google translate

Hepatitis C Virus (HCV) Testing Market